A federal appeals court on Wednesday declined to revive a lawsuit Walmart filed against the U.S. Department of Justice over federal law governing opioid prescription practices, a decision that comes as the retail giant faces separate litigation related to the nationwide opioid crisis.

Walmart sued the government last year, asking the U.S. District Court for the Eastern District of Texas to clarify pharmacists’ obligations to refuse to fill suspicious prescriptions under the Controlled Substance Act. In the complaint, Walmart said its pharmacists can be seen as improperly second-guessing doctors’ medical judgment when they refuse to fill prescriptions, and accused the government of having “unwritten expectations” for how the company and other pharmacies should handle opioid prescriptions.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]